Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
J. Michael Redmond currently holds 100,000 shares of BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Michael Redmond has been a net neutral trader of BJCT stock. They have purchased $0 and sold $0 worth of shares.
J. Michael Redmond's most recent insider trade was on Sep 19, 2024, when they sold 100,000 shares at $0.00 per share.
J. Michael Redmond serves as Executive at BIOJECT MEDICAL TECHNOLOGIES INC (BJCT). They have executed 15 insider transactions totaling $0 over their tenure at the company.
J. Michael Redmond holds the position of Executive at BIOJECT MEDICAL TECHNOLOGIES INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
J. Michael Redmond has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by J. Michael Redmond was on Sep 2, 2022, when they sold $240.0K worth of ODYY shares. This transaction involved 1,500,000 shares at $0.16 per share.
J. Michael Redmond currently owns 100,000 shares of BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of J. Michael Redmond's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. J. Michael Redmond has 15 Form 4 filings on record as an insider at BIOJECT MEDICAL TECHNOLOGIES INC.
Set alerts for J. Michael Redmond and 40,000+ other insiders.